Determinación de los mecanismos moleculares que controlan la señal de la citocina TGF-b y la cinasa PKA durante la diferenciación y función de linajes linfoides

Bases moleculares de la respuesta inmune protectora para el diseño de inmunoterapias contra cepas bacterianas multidrogoresistentes

Estudio de los señales moleculares en la interacción parasito-hospedero y su potencial terapeutico

Publicaciones

1. Cruz-Muñiz MY, López-Jacome LE, Hernández-Durán M, Franco-Cendejas R, Licona-Limón P, Ramos-Balderas JL, Martínez-Vázquez M, Belmont-Díaz JA, Wood TK, García-Contreras R. Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections. Int J Antimicrob Agents 2017, 49(1):88-92. Impact factor:5.283
2. García-Patiño MG, García-Contreras R, Licona-Limón P*. The immune response against Acinetobacter baumannii, an emerging pathogen in nosocomial infections. Front Immunol 2017, 8:441. doi: 10.3389/fimmu.2017.00441. *Autor corresponsal. Impact factor: 6.42
3. Bosurgi L, Cao YG, Cabeza-Cabrerizo M, Tucci A, Hughes LD, Kong Y, Weinstein JS, Licona-Limón P, Schmid ET, Pelorosso F, Gagliani N, Craft JE, Flavell RA, Ghosh S, Rothlin CV. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science 2017, 356(6342): 1072-1076. Impact factor: 47.72
4. Pérez-Vázquez D, Contreras-Castillo E, Licona-Limón P*. Innate Immune Memory, the missing piece of the immunological response. TIP Revista Especializada en Ciencias Químico-Biológicas, 21(Supl.1): 112-123, 2018. DOI: 10.22201/fesz.23958723e.2018.0.151. *Autor corresponsal. Impact factor:13.
5. Ruiz R, Roque A, Pineda E, Licona-Limón P, Valdez-Alarcon J, Lajud N. Early life stress accelerates age-induced effects on neurogenesis, depression and metabolic risk. Physoneuroendocrinology, 2018. 96: 203-211. Impact factor: 4.41.
6. López-Jácome E, Franco-Cendejas R, Quezada H, Morales-Espinosa R, Castillo-Juárez I, González-Pedrajo B, Fernández-Presas AM, Tovar-García A, Angarita-Zapata V, Licona-Limón P, Martínez-Vázquez M, García-Contreras R. The race between drug introduction and appearance of microbial resistance. Current balance and alternative approaches. Curr Opin Pharmacol 2019. 48:48-56. Impact factor: 4.3.
7. Amezcua-Vesely MC, Pallis P, Bielecki P, Low JS, Zhao J, Harman CCD, Kroehling L, Jackson R, Bailis W, Licona-Limón P, Xu H, Lijima N, Pillai PS, Kaplan DH, Weaver CT, Kluger Y, Kowalczyk MS, Iwasaki A, Pereira JP, Esplugues E, Gagliani N, Flavell RA. Effector Th17 cells give rise to long-lived TRM cells that are essential for an immediate response against bacterial infection. Cell 2019. 178(5): 1176-1188. Impact factor: 41.58
8. Kharwadkar R, Ulrich BJ, Abdul Qayum A, Koh B, Licona-Limón P, Flavell RA, Kaplan MH. Expression Efficiency of Multiple Il9 Reporter Alleles Is Determined by Cell Lineage. Immunohorizons 2020. 4(5):282-291. Impact factor: 1.93.
9. Xu H, Agalioti T, Zhao J, Steglich B, Wahib R, Amezcua-Vesely MC, Bielecki P, Bailis W, Jackson R, Perez D, Izbicki J, Licona-Limón P, Kaartinen V, Geginat J, Esplugues E, Tolosa E, Huber S, Flavell RA, Gagliani N. The induction and function of the anti-inflammatory fate of Th17 cells. Nat Commun 2020. 11, 3334. Impact factor: 14.91.
10. Tomar S, Ganesan V, Sharma A, Zeng C, Waggoner L, Smith A, Kim CH, Licona-Limón P, Reinhardt RL, Flavell RA, Wang YH. Hogan SP. IL-4-BAFT signaling directly modulates IL-9 producing mucosal mast cell (MMC9) function in experimental allergy. J Allergy Clin Immunol 2021. 147(1):280-295. Impact factor: 14.11.
11. Bielecki P, Riesenfeld AJ, Hütter JA, Torlai Triglia E, Kowalczyk MS, Ricardo-Gonzalez RR, Lian M, Amezcua Vesely MC, Kroehling L, Xu H, Slyper M, Muus C, Ludwig T, Kedaigle AJ, Steach HR, York AG, Skadow MH, Yaghoubi P, Dionne D, Jarret A, , McGee HM, Porter CBM, Licona-Limón P, Bailis W, Jackson RP, Gagliani N, Locksley RM, Regev A, Flavell RA. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature 2021. 592(7852):128-132. Impact factor: 49.96.
12. Huanosta-Murillo E, Alcántara-Hernández M, Hernández-Rico B, Victoria-Acosta G, Miranda-Cruz P, Domínguez-Gómez MA, Jurado-Santacruz F, Patiño-López G, Pérez-Koldenkova V, Palma-Guzmán A, Licona-Limón P, Fuentes-Pananá EM, Lemini-López A, Bonifaz LC. NLRP3 regulates IL-4 expression in TOX+CD4+ T cells of cutaneous T Cell Lymphoma to potentially promote Disease Progression. Front Immunol 2021.12:668369. Impact factor: 6.42.
13. Arzate-Mejía RG, Aparicio-Juárez A, Fuentes-Jiménez D, Molina-Villa T, Salinas LS, López-Casillas F, Valdés J, Licona-Limón P, Recillas-Targa F, Navarro RE. Uso del sistema CRISPR-Cas9 para la edición de genes en organismos modelo y líneas celulares. Mensaje Bioquímico 2021 (45): 134-156.
14. Olguín-Martínez E, Ruiz-Medina B, Licona-Limón P*. Tissue-specific molecular markers and heterogeneity in Type 2 Innate Lymphoid Cells. Front Immunol 2021.12:757967. *Autor corresponsal. Impact factor: 6.42.
15. Angeles-Floriano T, Rivera-Torruco G, García-Maldonado P, Juárez E, Gonzalez Y, Parra-Ortega I, Vilchis-Ordoñez A, Lopez-Martinez B, Arriaga-Pizano L, Orozco-Ruíz D, Torres-Nava JR, Licona-Limón P, López-Sosa F, Bremer A, Alvarez-Arellano L, Valle-Rios R. Cell Surface expression of GRP78 and CXCR4 is associated with childhood high-risk acute lymphoblastic leukemia at diagnostics. Sci Rep 2022. 12(1):2322. Impact factor: 4.38.
16. Olguín-Martínez E, Muñoz-Paleta O, Ruiz-Medina BE, Ramos-Balderas JL, Licona-Limón II, Licona-Limón P*. IL-33 and PKA pathway regulate ILC2 populations expressing IL-9 and ST2. Front Immunol 2022.13:787713.*Autor corresponsal. Impact factor: 6.42.

Circuito de Posgrado, Ciudad Universitaria
Alcaldía Coyoacán, C.P. 04510, México, CDMX

55 5623 7006
mdcbq@posgrado.unam.mx